论文信息 - Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. - 字舞流文

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.

B. Viollet | R. Deberardinis | Russell G. Jones | C. Thompson | M. Buzzai | F. Zhao | R. Amaravadi | J. Lum | C. Thompson | C. Thompson